Exciting developments are on the horizon in the world of pharmaceuticals and biotechnology as positive data emerges for RSV therapy and vaccine rollout. The past year has seen significant progress in RSV research, with the approval of multiple vaccines and a new treatment for infants targeting RSV disease.

In a cover story for this month, we delve into the implications of these vaccines and treatments reaching those in need, starting with the initial rollout in Spain and the potential lessons it holds for global distribution.

One of the highlights of this issue is an exclusive interview with the director of Biomedical Advanced Research and Development Authority (BARDA)’s medical countermeasures programs. The interview sheds light on BARDA’s future focus areas and strategies.

Delving deeper into the realm of pharmaceuticals, don’t miss out on insights into the pricing implications of the world’s most expensive therapy, the rising trend of molecular glues, and more.

Stay updated with the latest news and analysis from the pharmaceutical and biotech industry in the latest issue of Pharma Technology Focus. Explore in-depth coverage and expert analysis to stay informed about the ever-evolving landscape of healthcare innovation.